Showing results (51-60 of 801) with videos related to

Sort By:
Pageof 81
Annals of Hematology|February 1, 1995
Failure of repeated courses of high-dose intravenous immunoglobulin to induce stable remission in patients with chronic idiopathic thrombocytopenic purpuraC Schiavotto, M Ruggeri, F Rodeghiero
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|July 1, 1985
[Therapy with high-dose intravenous gamma globulin in the newborn infant with thrombocytopenia from passive immunization]G F Ronconi, G Castaman, E Fantuz, et al.
American Journal of Hematology|May 1, 1993
Desmopressin-induced thrombocytopenia in type I platelet discordant von Willebrand diseaseG Castaman, F Rodeghiero, A Lattuada, et al.
British Journal of Haematology|January 1, 1995
Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand diseaseG Castaman, A Lattuada, P M Mannucci, et al.
Haematologica|November 1, 1993
Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literatureC Schiavotto, M Ruggeri, F Rodeghiero
Vox Sanguinis|January 1, 1992
Replacement therapy with virus-inactivated plasma concentrates in von Willebrand diseaseF Rodeghiero, G Castaman, D Meyer, et al.
Haematologica|November 1, 1993
Fibrinogen survival and fibrinopeptide A in acute leukemiaG Castaman, E Galloni, A V Dri, et al.
British Journal of Haematology|May 3, 2000
Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effectG Castaman, J C Eikenboom, E Missiaglia, et al.
British Journal of Haematology|March 1, 1997
Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generationG Castaman, L Yu-Feng, E Battistin, et al.
American Journal of Hematology|January 1, 1991
Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiencyF Rodeghiero, A Tosetto, E Di Bona, et al.
Pageof 81